ONO Pharmaceutical Co ( (JP:4528) ) has shared an announcement.
Ono Pharmaceutical Co., Ltd. has announced its commitment to strengthening corporate governance by enhancing the functions of its Board of Directors and Audit & Supervisory Board. The company is also systematically reducing its cross-shareholdings to increase corporate value and is promoting diversity, equity, and inclusion within its workforce to improve employee engagement and unity. These initiatives are expected to positively impact the company’s operations and industry positioning.
More about ONO Pharmaceutical Co
Ono Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on discovering innovative pharmaceutical products that benefit patients. The company emphasizes strong corporate governance and diversity, aiming to enhance management transparency and corporate value.
YTD Price Performance: 4.44%
Average Trading Volume: 11,172
Technical Sentiment Signal: Buy
Current Market Cap: $5.27B
See more data about 4528 stock on TipRanks’ Stock Analysis page.